Research Paper Volume 13, Issue 5 pp 7147—7165
No difference in hepatocellular carcinoma risk in chronic hepatitis B patients treated with tenofovir vs entecavir: evidence from an updated meta-analysis
Figure 1. The flowchart of identifying relevant studies. HIV, human immunodeficiency virus; HCV, hepatitis C virus; HCC, hepatocellular carcinoma.